Irish and American researchers have identified a potential new way to counter treatment‑resistant prostate cancer by ...

CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...

The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of ...

Results from the phase 2 Daro-PET study (NCT05900973) showed that prostate-specific membrane antigen (PSMA) expression was boosted with short-course darolutamide (Nubeqa) in patients with high-risk ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

A new prostate imaging system for the detection of prostate cancer has been evaluated by Weiss and colleagues. Prostate mechanical imaging (PMI; Artann Laboratories, Trenton, NJ) is accomplished by ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ACCESS ...

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

Prostate cancer often has no symptoms early on, but you may later have frequent urination, or blood in your urine or semen. Although less common, you may have painful ejaculation with prostate cancer.

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of specific biologic targets—such as enzymes or receptors—by inhibiting or ...

This powerful true account of love, exile, and friendship earns one of the top honors in the annual Reader Views ...

Your face changes throughout your life. The process of growing from a baby to an adult is the most dramatic change, but the changes continue throughout adulthood. Weight changes, pregnancy, changes in ...